TC
ELOS

TFS Capital’s Syneron Medical Ltd ELOS Stock Holding History

TFS Capital’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-34,689
Closed -$366K – 893
2017
Q1 		$366K Sell
34,689
-71,847
-67% -$695K 0.12% 323
2016
Q4 		$895K Buy
+106,536
New +$835K 0.24% 152
2016
Q3 		– Sell
-11,349
Closed -$87K – 1171
2016
Q2 		$87K Sell
11,349
-1,348
-11% -$9.61K 0.02% 878
2016
Q1 		$93K Buy
+12,697
New +$91K 0.01% 901
2015
Q4 		– Sell
-17,697
Closed -$127K – 1052
2015
Q3 		$127K Buy
17,697
+7,441
+73% +$71.5K 0.01% 790
2015
Q2 		$109K Sell
10,256
-604
-6% -$7.07K 0.01% 809
2015
Q1 		$134K Buy
10,860
+227
+2% +$2.51K 0.01% 845
2014
Q4 		$99K Sell
10,633
-355
-3% -$3.42K 0.01% 913
2014
Q3 		$110K Sell
10,988
-37,414
-77% -$381K 0.01% 962
2014
Q2 		$500K Sell
48,402
-26,894
-36% -$291K 0.04% 641
2014
Q1 		$937K Sell
75,296
-12,545
-14% -$149K 0.06% 485
2013
Q4 		$1.08M Sell
87,841
-6,490
-7% -$67.4K 0.05% 523
2013
Q3 		$813K Sell
94,331
-44,794
-32% -$387K 0.04% 664
2013
Q2 		$1.21M Buy
+139,125
New +$1.24M 0.05% 525

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
DGHMC
Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

TFS Capital's ELOS Position: Q2 2017 in Review

TFS Capital sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 34,689 shares — an estimated $366K sold.

TFS Capital first reported a position in ELOS in Q2 2013 and held it in 14 quarters. The position peaked at $1.21M in Q2 2013. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

  • TFS Capital reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
  • TFS Capital sold 34,689 Syneron Medical Ltd shares in Q2 2017, an estimated $366K.
  • TFS Capital first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 14 quarters.
  • TFS Capital's Syneron Medical Ltd position peaked at $1.21M in Q2 2013.
  • 79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.